Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?

Brain

Volumn 123, Issue 6, 2000, Pages 1112-1121

  Tassin, Johann ^a   Dürr, Alexandra ^a,b,c   Bonnet, Anne Marie ^a,b   Gil, Roger ^f   Vidailhet, Marie ^a,e   Lücking, Christoph B ^a   Goas, Jean Yves ^g   Durif, Franck ^m   Abada, Myriem ^h   Echenne, Bernard ⁱ   Motte, Jacques ^j   Lagueny, Alain ^k   Lacomblez, Lucette ^d   Jedynak, Pierre ^l   Bartholomé, Barbara ⁿ   Agid, Yves ^a,b   Brice, Alexis ^a,b,c,d  

^a INSERM   (France)

^b Fed de Neurologie Mazarin   (France)

^c CH de la Miletrie   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f University of Poitiers   (France)

^g SERVICE DE RHUMATOLOGIE   (France)

^h SERVICE DE RHUMATOLOGIE   (France)

ⁱ HÔPITAL SAINT ELOI   (France)

^j AMERICAN HOSPITAL OF PARIS   (France)

^k HAUT LÉVÊQUE HOSPITAL   (France)

^l FOCH HOSPITAL   (France)

^m Centre Hospitalier et Universitaire de Beni Messous Algiers   (Algeria)

ⁿ ST JOSEF HOSPITAL   (Germany)

more..

Author keywords

DOPA responsive dystonia; GTPCH I gene; Mutations; Phenotype genotype correlation; Sequence analysis

Indexed keywords

GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LEVODOPA;

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 6; CLINICAL ARTICLE; CONTROLLED STUDY; DYSTONIA; FEMALE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MALE; MISSENSE MUTATION; NONSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL;

EID: 0342369398     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/123.6.1112     Document Type: Article

References (30)

1. Abbas N, Lucking CB, Ricard S, Durr A, Bonifati V, De Michele G, et al. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Hum Mol Genet 1999; 8: 567-74.
2. Bandmann O, Nygaard TG, Surtees R, Marsden CD, Wood NW, Harding AE. Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet 1996; 5: 403-6.
3. Bandmann O, Valente EM, Holmans P, Surtees RA, Walters JH, Wevers RA, et al. Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol 1998; 44: 649-56.
4. Beyer K, Lao-Villadoniga JI, Vecino-Bilbao B, Cacabelos R, De la Fuente-Fernandez R. A novel point mutation in the GTP cyclohydrolase I gene in a Spanish family with hereditary progressive and dopa responsive dystonia [letter]. J Neurol Neurosurg Psychiatry 1997; 62: 420-1.
5. Blau N, Ichinose H, Nagatsu T, Heizmann CW, Zacchello F, Burlina AB. A missense mutation in a patient with guanosine triphosphate cyclohydrolase I deficiency missed in the newborn screening program. J Pediatr 1995; 126: 401-5.
6. Fletcher NA, Thompson PD, Scadding JW, Marsden CD. Successful treatment of childhood onset symptomatic dystonia with levodopa. J Neurol Neurosurg Psychiatry 1993; 56: 865-7.
7. Furukawa Y, Shimadzu M, Rajput AH, Shimizu Y, Tagawa T, Mori H, et al. GTP-cyclohydrolase I gene mutations in hereditary progressive and dopa-responsive dystonia. Ann Neurol 1996; 39: 609-17.
8. Furukawa Y, Kish SJ, Bebin EM, Jacobson RD, Fryburg JS, Wilson WG, et al. Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations. Ann Neurol 1998; 44: 10-6.
9. Hattori N, Matsumine H, Asakawa S, Kitada T, Yoshino H, Elibol B, et al. Point mutations (Thr240Arg and Ala311Stop) in the Parkin gene. Biochem Biophys Res Commun 1998; 249: 754-8.
10. Hirano M, Ueno S. Mutant GTP cyclohydrolase I in autosomal dominant dystonia and recessive hyperphenylalaninemia. Neurology 1999; 52: 182-4.
11. Hirano M, Tamaru Y, Nagai Y, Ito H, Imai T, Ueno S. Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia dopa responsive dystonia. Biochem Biophys Res Commun 1995; 213: 645-51.
12. Hirano M, Tamaru Y, Ito H, Matsumoto S, Imai T, Ueno S. Mutant GTP cyclohydrolase I mRNA levels contribute to dopa-responsive dystonia onset. Ann Neurol 1996; 40: 796-8.
13. Hirano M, Yanagihara T, Ueno S. Dominant negative effect of GTP cyclohydrolase I mutations in dopa-responsive hereditary progressive dystonia. Ann Neurol 1998; 44: 365-71.
14. Ichinose H, Ohye T, Takahashi E, Seki N, Hori T, Segawa M, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994; 8: 236-42.
15. Illarioshkin SN, Markova ED, Slominsky PA, Miklina NI, Popova SN, Limborska SA, et al. The GTP cyclohydrolase I gene in Russian families with dopa-responsive dystonia. Arch Neurol 1998; 55: 789-92.
16. Jarman PR, Bandmann O, Marsden CD, Wood NW. GTP cyclohydrolase I mutations in patients with dystonia responsive to anticholinergic drugs. J Neurol Neurosurg Psychiatry 1997; 63: 304-8.
17. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392: 605-8.
18. Knappskog PM, Flatmark T, Mallet J, Ludecke B, Bartholome K. Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum Mol Genet 1995; 4: 1209-12.
19. Lucking CB, Abbas N, Durr A, Bonifati V, Bonnet AM, de Broucker T, et al. Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism [letter]. Lancet 1998; 352: 1355-6.
20. Lucking CB, Durr A, Bonifati V, Vaughan J, De Michele G, Gasser T, et al. Early onset parkinsonism and parkin gene mutations. N Engl J Med. In press 2000.
21. Ludecke B, Dworniczak B, Bartholome K. A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome. Hum Genet 1995; 95: 123-5.
22. Ludecke B, Knappskog PM, Clayton PT, Surtees RA, Clelland JD, Heales SJ, et al. Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum Mol Genet 1996; 5: 1023-8.
23. Mori H, Kondo T, Yokochi M, Matsumine H, Nakagawa-Hattori Y, Miyake T, et al. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology 1998; 51: 890-2.
24. Nygaard TG. Dopa-responsive dystonia. [Review]. Curr Opin Neurol 1995; 8: 310-3.
25. Nygaard TG, Trugman JM, de Yebenes JG, Fahn S. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology 1990; 40: 66-9.
26. Nygaard TG, Wilhelmsen KC, Risch NJ, Brown DL, Trugman JM, Gilliam TC, et al. Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nat Genet 1993; 5: 386-91.
27. Rajput AH, Gibb WR, Zhong XH, Shannak KS, Kish S, Chang LG, et al. Dopa-responsive dystonia: pathological and biochemical observations in a case. Ann Neurol 1994; 35: 396-402.
28. Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 1976; 14: 215-33.
29. Togari A, Ichinose H, Matsumoto S, Fujita K, Nagatsu T. Multiple mRNA forms of human GTP cyclohydrolase I. Biochem Biophys Res Commun 1992; 187: 359-65.
30. van den Heuvel LP, Luiten B, Smeitink JA, de Rijk-van Andel JF, Hyland K, Steenbergen-Spanjers GC, et al. A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch population. Hum Genet 1998; 102: 644-6.